MenHibrix is a vaccine given to infants to help protect them from invasive diseases, such as meningitis, pneumonia, and bloodstream infections. It works by exposing the body to certain bacteria, but without risking the actual diseases. The vaccine is usually given as four doses, with the first dose typically at two months of age. Possible side effects include irritability, drowsiness, and reactions at the injection site.
What Is MenHibrix?MenHibrix® (Hib vaccine and meningococcal vaccine) is a childhood vaccine. It is a combined vaccine that provides protection against the following diseases:
- Invasive disease caused by Haemophilus influenzae type b (Hib), a type of bacteria that can cause potentially life-threatening diseases.
- Invasive meningococcal disease cause by the Neisseria meningitidis bacteria.
Invasive diseases include many different types of serious infections, such as meningitis, pneumonia, and bloodstream infections. MenHibrix is a childhood vaccine approved for use in infants.
Thimerosal Content and Other ConcernsMenHibrix does not contain thimerosal (a mercury-containing preservative). Parents who are concerned about exposing their children to thimerosal can be confident that this vaccine does not even contain trace amounts. Some parents are concerned about the aluminum content of vaccines as well; MenHibrix does not contain any aluminum.
This vaccine is not made from human fetal components or animal components, as some vaccines are.